Zobrazeno 1 - 10
of 122
pro vyhledávání: ''
Autor:
Ryuji Uozumi, Y. Kitazume, T. Yoshizawa, K. Hashiguchi, Katsuyuki Takahashi, T. Arai, M. Yamaguchi, T. Yamazaki, Y. Sato, Y. Murachi, M. Tsuchiya, Hironobu Hashimoto, Hirotoshi Iihara, Yuka Fujita, A. Yokoyama, M. Takahashi, Hironori Fujii, Y. Hosokawa, T. Mikami, I. Morozumi
Publikováno v:
Annals of Oncology. 32:S576-S577
Autor:
Niall C. Tebbutt, John M. Mariadason, David S. Williams, Timothy J. Price, Daniel D. Buchanan, Jennifer Mooi, Chee Khoon Lee, Amanda R. Townsend, Jennifer E. Hardingham, Pratyaksha Wirapati, Rebecca Asher, Sabine Tejpar, P S Savas
Publikováno v:
Annals of Oncology. 29:2240-2246
Background: The consensus molecular subtypes (CMS) is a transcriptome-based classification of colorectal cancer (CRC) initially described in early-stage cohorts, but the associations of CMS with treatment outcomes in the metastatic setting are yet to
Autor:
Michio Inukai, S. Kaihara, Shinichi Yoshioka, Masato Matsuura, T. Kyogoku, Hisateru Yasui, Yasuhiro Miyake, Akihito Tsuji, Yoshihiro Okita, Toshihiko Matsumoto, Takeshi Kotake, T. Kato, T. Watanabe, Hironaga Satake, Masahito Kotaka, Hiroaki Tanioka, H. Hashida
Publikováno v:
Annals of Oncology. 32:S165-S166
Autor:
Y-M. Sun, Y-H. Gao, Z-F. Zeng, X-Z. Wang, Y. Cheng, Jian Lei, W. Wang, W-L. Li, Y-Z. Zhuang, Z-G. Wu, X-B. Wan, Z-Z. Pan, Y-F. Li, P-R. Ding, Y-K. Ren, Y-Z Li, D-S. Wan, Z-Q. Wang, Rongxin Zhang, C-K. Yang
Publikováno v:
Annals of Oncology. 32:S1296
Publikováno v:
Annals of Oncology
Background: Alike other tumor types, it was recommended that the management of locally advanced rectal cancer (LARC) during the COVID outbreak would shift towards hypofractionated RT schemes. Short-course neoadjuvant radiotherapy (SCRT) is comparable
Autor:
S. Ghomari-Bezzar, N. Mkedder
Publikováno v:
Annals of Oncology. 32:S198
Autor:
G.J.M. Creemers, Stefan M. Willems, Eric Strengman, A.M.T. van der Velden, A.J. ten Tije, W. W. J. de Leng, Frans L. G. Erdkamp, C.J.A. Punt, Miangela M. Lacle, B.C. Tanis, Kaitlyn K.H. Goey, F. de Jongh, Sjoerd G. Elias, Miriam Koopman, G J A Offerhaus, H. van Tinteren
Publikováno v:
Annals of Oncology, 28(9), 2128. Oxford University Press
Annals of oncology, 28(9), 2128-2134. Oxford University Press
Annals of oncology, 28(9), 2128-2134. Oxford University Press
Background The phase 3 CAIRO3 study showed that capecitabine plus bevacizumab (CAP-B) maintenance treatment after six cycles capecitabine, oxaliplatin, and bevacizumab (CAPOX-B) in metastatic colorectal cancer (mCRC) patients is effective, without co
Autor:
M. Vera Merino, B. López-Zamora, M. Almada, D. Angel Schutte, S. Zunino, D. Venencia, L. Suarez Villasmil, Y. Schworer
Publikováno v:
Annals of Oncology. 31:S155-S156
Autor:
Keiichiro Ishibashi, Koichi Okamoto, Shigeki Yamaguchi, Hideyuki Mishima, Mototsugu Shimokawa, Yoshinori Kagawa, Hitoshi Ojima, Yoshiyuki Yamaguchi, Takeshi Nagasaka, Akira Sawaki, Shingo Noura, Akihito Tsuji, A. Tomibayashi, Yoshiaki Shindo, Hiroaki Tanioka, Yoshihisa Shimada, Ryo Inada, Yoshinori Munemoto, Yasushi Tsuji, Masazumi Okajima
Publikováno v:
Annals of Oncology. 30:v215-v216
Background The C-cubed study investigates the optimal treatment strategy in patients with untreated metastatic colorectal cancer (mCRC). We tested the superiority of a sequential treatment of FP+BEV followed by OX+FP+BEV (arm A: OX “wait & go”) a
Autor:
Lieke H.J. Simkens, A.M.T. van der Velden, C.J.A. Punt, A.J. van de Wouw, Mathijs P. Hendriks, G.J.M. Creemers, T. Van Voorthuizen, A.J. ten Tije, R.J. van Alphen, M. Los, Linda Mol, Johannes J.M. Kwakman, M. Koopman, Erik W. Muller, E. van Werkhoven, Marco B. Polee, J. M. van Rooijen
Publikováno v:
Annals of Oncology. 30:v233-v234
Background SALTO is a multi-center, open-label phase III trial in which 161 Western patients with metastatic colorectal cancer (mCRC) were randomized between capecitabine and S-1. The primary endpoint, a lower incidence of hand-foot syndrome (HFS) fo